Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zomedica Corp.ZOMDF · Entity 6884 | Director | November 17, 2025 | November 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zomedica Corp.
Report date November 17, 2025 · Filed November 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $0.10 · Expires 2035-11-16 | Direct | 1,975,033 |
Reported balance
After 2025-11-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-17 · Grant · Acquired 1,975,033 · Balance 1,975,033 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 17, 2025 Filed Nov 18, 2025 21:45 UTC | Zomedica Corp. ZOMDF · Entity 6884 | GrantStock Appreciation Right · Derivative | 1,975,033 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001654954-25-013224 · section16.xml · derivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,975,033 Underlying: Common · 1,975,033 shares Expires 2035-11-16 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:24 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 100,000 | $0.07 | $6,900.00 |
DisclosureSEC source: 0001654954-25-002951 · section16.xml · nonDerivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Read SEC document |
| March 17, 2025 Filed Mar 20, 2025 13:52 UTC | Zomedica Corp. ZOM · Entity 6884 | PurchaseCommon Stock, without par value | 100,000 | $0.07 | $6,900.00 |
DisclosureSEC source: 0001654954-25-003059 · section16.xml · nonDerivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,900 F1 · balance_after: A correction is being made to the Form K filed on 3/18/2025 to add shares previously held by Mr. Williams and correct total securities beneficially owned following the transaction Read SEC document |
| November 10, 2024 Filed Nov 26, 2024 21:09 UTC Amendment | Zomedica Corp. ZOM · Entity 6884 | GrantStock Appreciation Rights · Derivative | 1,975,033 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0001654954-24-014916 · section16.xml · derivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,975,033 Underlying: Common · 1,975,033 shares Expires 2034-11-10 F1 · date: Amendment to correct name of recipient. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 23:06 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantOptions to Buy Common Stock · Derivative | 1,465,727 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001654954-22-016439 · section16.xml · derivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,465,727 Underlying: Common Stock · 1,465,727 shares Expires 2022-12-09 F1 · derivative.exercise_date: The stock options vest annually in four equal installments commencing on December 9, 2023. Read SEC document |
| May 12, 2021 Filed May 13, 2021 15:00 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 800,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001171843-21-003481 · ownership.xml · derivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Shares, without par value · 800,000 shares Expires 2031-05-12 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing December 31, 2021. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:10 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001171843-20-001785 · ownership.xml · derivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Shares, without par value · 200,000 shares Expires 2025-03-13 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing March 13, 2020. Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 21:13 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-000264 · ownership.xml · derivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Shares, without par value · 400,000 shares Expires 2021-01-10 F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| December 20, 2018 Filed Dec 28, 2018 00:01 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock Option (right to buy) · Derivative | 26,900 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0000905718-18-001001 · zomedica_form4dec202018.xml · derivative · entry 3 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 200,000 shares Expires 2018-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. Read SEC document |
| December 20, 2018 Filed Dec 28, 2018 00:01 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Shares, without par value | 26,900 | $1.20 | $32,280.00 |
DisclosureSEC source: 0000905718-18-001001 · zomedica_form4dec202018.xml · nonDerivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2018 Filed Jun 12, 2018 21:50 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Shares, without par value | 1,000 | $1.92 | $1,920.00 |
DisclosureSEC source: 0000905718-18-000563 · zomedica_form4jun112018.xml · nonDerivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 20:35 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Shares, without par value | 500 | $1.93 | $965.00 |
DisclosureSEC source: 0000905718-18-000552 · zomedica_form4may312018.xml · nonDerivative · entry 2 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,000 Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:35 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Shares, without par value | 1,500 | $1.91 | $2,865.00 |
DisclosureSEC source: 0000905718-18-000552 · zomedica_form4may312018.xml · nonDerivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,500 Read SEC document |
| May 24, 2018 Filed May 29, 2018 20:07 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Shares, without par value | 500 | $1.92 | $960.00 |
DisclosureSEC source: 0000905718-18-000544 · zomedica_form4may212018.xml · nonDerivative · entry 7 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,000 Read SEC document |
| May 23, 2018 Filed May 29, 2018 20:07 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Shares, without par value | 12 | $1.95 | $23.40 |
DisclosureSEC source: 0000905718-18-000544 · zomedica_form4may212018.xml · nonDerivative · entry 6 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,500 Read SEC document |
| May 23, 2018 Filed May 29, 2018 20:07 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Shares, without par value | 88 | $1.91 | $168.08 |
DisclosureSEC source: 0000905718-18-000544 · zomedica_form4may212018.xml · nonDerivative · entry 5 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,512 Read SEC document |
| May 23, 2018 Filed May 29, 2018 20:07 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Shares, without par value | 400 | $1.92 | $768.00 |
DisclosureSEC source: 0000905718-18-000544 · zomedica_form4may212018.xml · nonDerivative · entry 4 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,600 Read SEC document |
| May 22, 2018 Filed May 29, 2018 20:07 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Shares, without par value | 500 | $1.93 | $965.00 |
DisclosureSEC source: 0000905718-18-000544 · zomedica_form4may212018.xml · nonDerivative · entry 3 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,000 Read SEC document |
| May 21, 2018 Filed May 29, 2018 20:07 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Shares, without par value | 400 | $2.00 | $800.00 |
DisclosureSEC source: 0000905718-18-000544 · zomedica_form4may212018.xml · nonDerivative · entry 2 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,500 Read SEC document |
| May 21, 2018 Filed May 29, 2018 20:07 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Shares, without par value | 100 | $2.03 | $203.00 |
DisclosureSEC source: 0000905718-18-000544 · zomedica_form4may212018.xml · nonDerivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,900 Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 20:46 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock Option (right to buy) · Derivative | 140,000 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000332 · zomedica_form4mar232018.xml · derivative · entry 3 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 140,000 shares Expires 2018-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 20:46 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Shares, without par value | 140,000 | $0.20 | $28,000.00 |
DisclosureSEC source: 0000905718-18-000332 · zomedica_form4mar232018.xml · nonDerivative · entry 1 Williams Rodney James · CIK 0001722780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.